 ROCKAWAY, N.J., Jan. 19, 2021 GLOBE NEWSWIRE -- electroCore, Inc. Nasdaq: ECOR, a commercial-stage bioelectronic medicine company, today announced that Centers for Medicare and Medicaid Services CMS published its most recent Level II Healthcare Common Procedure Coding System HCPCS decisions on January 15, 2021, establishing a unique code K1020 Non-invasive vagus nerve stimulator. The coding decision covers the Companys gammaCore SapphireTM D and is in response to the application submitted by the Company during CMS second biannual 2020 Coding Cycle for non-drug and non-biological items and services, which application focused on the clinical and economic advantages of gammaCore therapy. All final coding decisions for the second biannual 2020 Coding Cycle for non-drug and non-biological items and services will go into effect on April 1, 2021. 